Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geon Kim

Showing results (71-80 of 355) with videos related to

Pageof 36
Sort By:
Journal of Nanoscience and Nanotechnology|December 1, 2007
Quantum mechanical device modeling: FinFET having an isolated n+/p+ gate region strapped with poly-siliconHan-Geon Kim, Joong-Sik Kim, Young-Kyu Kim, et al.
Archives of Biochemistry and Biophysics|August 30, 2008
Compound C inhibits clonal expansion of preadipocytes by increasing p21 level irrespectively of AMPK inhibitionMinwoo Nam, Woo Hyung Lee, Eun Ju Bae, et al.
Sensors (Basel, Switzerland)|March 26, 2022
Review of Intentional Electromagnetic Interference on UAV Sensor Modules and Experimental StudySung-Geon Kim, Euibum Lee, Ic-Pyo Hong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2011
Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein βKyoung Noh, Young Mi Kim, Young Woo Kim, et al.
Journal of Clinical Medicine|February 13, 2020
Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital SettingKwi Suk Kim, Young Hee Choi, Aree Moon, et al.
Nanoscale|August 14, 2023
Inorganic nanoparticle agents for enhanced chemodynamic therapy of tumoursSagang Koo, Young Geon Kim, Nohyun Lee, et al.
Biosensors & Bioelectronics|October 16, 2018
Learning-based screening of hematologic disorders using quantitative phase imaging of individual red blood cellsGeon Kim, YoungJu Jo, Hyungjoo Cho, et al.
Expert Opinion on Therapeutic Patents|March 17, 2011
Toll-like receptor modulators: a patent review (2006-2010)Shaherin Basith, Balachandran Manavalan, Gwang Lee, et al.
Toxicological Research|November 27, 2013
Applications of genetically modified tools to safety assessment in drug developmentHee Yeon Kay, Hongmin Wu, Seo In Lee, et al.
International Immunopharmacology|August 18, 2004
Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-alpha inhibitionMin Kyung Cho, Young Pyo Jang, Young Choong Kim, et al.
Pageof 36

Showing results (71-80 of 355) with videos related to

Sort By:
Pageof 36
Journal of Nanoscience and Nanotechnology|December 1, 2007
Quantum mechanical device modeling: FinFET having an isolated n+/p+ gate region strapped with poly-siliconHan-Geon Kim, Joong-Sik Kim, Young-Kyu Kim, et al.
Archives of Biochemistry and Biophysics|August 30, 2008
Compound C inhibits clonal expansion of preadipocytes by increasing p21 level irrespectively of AMPK inhibitionMinwoo Nam, Woo Hyung Lee, Eun Ju Bae, et al.
Sensors (Basel, Switzerland)|March 26, 2022
Review of Intentional Electromagnetic Interference on UAV Sensor Modules and Experimental StudySung-Geon Kim, Euibum Lee, Ic-Pyo Hong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2011
Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein βKyoung Noh, Young Mi Kim, Young Woo Kim, et al.
Journal of Clinical Medicine|February 13, 2020
Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital SettingKwi Suk Kim, Young Hee Choi, Aree Moon, et al.
Nanoscale|August 14, 2023
Inorganic nanoparticle agents for enhanced chemodynamic therapy of tumoursSagang Koo, Young Geon Kim, Nohyun Lee, et al.
Biosensors & Bioelectronics|October 16, 2018
Learning-based screening of hematologic disorders using quantitative phase imaging of individual red blood cellsGeon Kim, YoungJu Jo, Hyungjoo Cho, et al.
Expert Opinion on Therapeutic Patents|March 17, 2011
Toll-like receptor modulators: a patent review (2006-2010)Shaherin Basith, Balachandran Manavalan, Gwang Lee, et al.
Toxicological Research|November 27, 2013
Applications of genetically modified tools to safety assessment in drug developmentHee Yeon Kay, Hongmin Wu, Seo In Lee, et al.
International Immunopharmacology|August 18, 2004
Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-alpha inhibitionMin Kyung Cho, Young Pyo Jang, Young Choong Kim, et al.
Pageof 36